EL

Elevance Health Inc. Common Stock Earnings Recaps

ELV Health Care 2 recaps
Next earnings: October 20, 2026 (estimated) · full calendar
Q2 2026 Jul 17, 2026

Elevance Health’s stock fell 12.6% as investors reacted negatively to cautious commentary on Medicaid margin pressures and the ongoing strategic exits from underperforming Medicaid markets, signaling concerns about margin compression and deceleration in this key segment despite raised EPS guidance.

Key takeaways
  • The company raised 2026 adjusted EPS guidance to at least $27, supported by disciplined cost management and targeted investments.
  • Medicaid continues to face a dynamic and elevated cost trend environment, with the 2026 operating margin expected to remain at a trough level and margins described as "appropriately prudent and unchanged."
  • Strategic market exits, including the recent decision to leave the D.C. Medicaid market, highlight challenges in generating sustainable returns in Medicaid.
  • Medicare Advantage shows progress due to deliberate repositioning, contributing positively across the portfolio but not enough to offset Medicaid concerns.
  • Investments in AI-enabled care management and digital tools aim to enhance cost detection and clinical intervention but remain future-oriented with uncertain impact on near-term results.
Full recap
Q1 2026 Apr 22, 2026

Elevance Health delivered a strong first quarter, exceeding expectations through solid business performance, strategic realignment, and advanced AI integration, prompting a raised full-year EPS guidance of at least $26.75.

Key takeaways
  • First quarter results benefited from improved claims experience, ACA seasonality, and nonrecurring investment income.
  • Strategic initiatives—including leadership realignment and scaling AI—are enhancing operational efficiency and clinical outcomes.
  • Carelon’s integrated, risk-based solutions reduced hospital readmissions by 20% and achieved over 10% savings on post-acute care.
  • Progress in Medicaid and Medicare Advantage management supports mid-single-digit operating margins, with ongoing focus on risk adjustment and long-term value.
  • Commercial and individual ACA businesses show disciplined pricing and modest retention improvements, bolstering future growth prospects.
Full recap

Go deeper on ELV and the wider market.

All earnings recaps Browse the latest results across the market. Stock directory Browse companies by sector and market. Highest-yield stocks A curated screen of top dividend payers. Investing glossary Plain-English definitions for every metric.